Preclinical Research

CKD is a slow and progressive loss of kidney function over several years, which can eventually cause permanent kidney failure. CKD often goes undetected and undiagnosed until the disease is well advanced, and the damage is irreversible resulting in poor survival rates. There are estimated to be 700 million cases of CKD worldwide, and currently there is no cure.

Organ-on-chip and tissue-on-chip models continue to advance drug discovery

Peptide drug targets two cancer proteins for increased specificity and uptake

Data on HOOKIPA’s cancer therapeutics have been published in Cell Reports Medicine

Unique AI method developed at Chalmers for generating proteins could speed up drug development

Wild Biotech says it is discovering millions of previously unknown potential human therapeutics

New discoveries suggest it is on par with therapeutics and speeds the process of recovery and adoption of personalized treatment

Broad Institute launches the Eric and Wendy Schmidt Center for better understanding programs of life

Bioasis announces publication evaluating CNS delivery of siRNA via the company’s xB³ platform

Making the rounds of brain-related therapeutic and diagnostic R&D, with a focus on neurodegenerative disease and dementia